3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
42
Colonic Neoplasms
14
Rectal Neoplasms
13
Neoplasms
12
Neoplasm Metastasis
12
Head and Neck Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Recurrence
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Tumors
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Exanthema
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Panitumumab
×
Clear all
No trials found.